Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 252

1.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Feb 5;92(6):e536-e547. doi: 10.1212/WNL.0000000000006876. Epub 2019 Jan 11.

PMID:
30709964
2.

Amyotrophic lateral sclerosis diagnostic index: Toward a personalized diagnosis of ALS.

Geevasinga N, Howells J, Menon P, van den Bos M, Shibuya K, Matamala JM, Park SB, Byth K, Kiernan MC, Vucic S.

Neurology. 2019 Jan 11. pii: 10.1212/WNL.0000000000006861. doi: 10.1212/WNL.0000000000006861. [Epub ahead of print]

PMID:
30635486
3.

Comparison of two different radiofrequency ablation systems for renal artery denervation: Evaluation of short-term and long-term follow up.

Al Raisi SI, Pouliopoulos J, Qian P, King P, Byth K, Barry MT, Swinnen J, Thiagalingam A, Kovoor P.

Catheter Cardiovasc Interv. 2019 Feb 15;93(3):E105-E111. doi: 10.1002/ccd.28038. Epub 2018 Dec 14.

PMID:
30549404
4.

A systematic description of the post-EMR defect to identify risk factors for clinically significant post-EMR bleeding in the colon.

Desomer L, Tate DJ, Bahin FF, Awadie H, Chiang B, Holt B, Byth K, Bourke MJ.

Gastrointest Endosc. 2019 Mar;89(3):614-624. doi: 10.1016/j.gie.2018.11.023. Epub 2018 Nov 29.

PMID:
30503846
5.

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6.

McCoull W, Cheung T, Anderson E, Barton P, Burgess J, Byth K, Cao Q, Castaldi MP, Chen H, Chiarparin E, Carbajo RJ, Code E, Cowan S, Davey PR, Ferguson AD, Fillery S, Fuller NO, Gao N, Hargreaves D, Howard MR, Hu J, Kawatkar A, Kemmitt PD, Leo E, Molina DM, O'Connell N, Petteruti P, Rasmusson T, Raubo P, Rawlins PB, Ricchiuto P, Robb GR, Schenone M, Waring MJ, Zinda M, Fawell S, Wilson DM.

ACS Chem Biol. 2018 Nov 16;13(11):3131-3141. doi: 10.1021/acschembio.8b00698. Epub 2018 Oct 17.

PMID:
30335946
6.

Thermal Ablation of Mucosal Defect Margins Reduces Adenoma Recurrence After Colonic Endoscopic Mucosal Resection.

Klein A, Tate DJ, Jayasekeran V, Hourigan L, Singh R, Brown G, Bahin FF, Burgess N, Williams SJ, Lee E, Sidhu M, Byth K, Bourke MJ.

Gastroenterology. 2019 Feb;156(3):604-613.e3. doi: 10.1053/j.gastro.2018.10.003. Epub 2018 Oct 6.

PMID:
30296436
7.

Fine needle aspiration biopsy cytology of phyllodes tumour and fibroadenoma: A cytomorphological study of 104 cases.

Wang XY, Mahajan H, Dickinson N, Cox C, Byth K, Bayly A, Cahill MA, Pathmanathan N.

Diagn Cytopathol. 2018 Nov;46(11):927-935. doi: 10.1002/dc.24021. Epub 2018 Oct 3.

PMID:
30284391
8.

Cutaneous adverse events of anti-programmed death 1 antibodies combined with anti-cytotoxic T-lymphocyte-associated protein 4 therapy use in patients with metastatic melanoma.

Hwang SJE, Park JJW, Wakade D, Chou S, Byth K, Fernandez-Penas P.

Melanoma Res. 2018 Sep 29. doi: 10.1097/CMR.0000000000000518. [Epub ahead of print]

PMID:
30273233
9.

Tanning, selfies and social media.

Abbott LM, Byth K, Fernandez-Penas P.

Australas J Dermatol. 2019 Feb;60(1):82-84. doi: 10.1111/ajd.12933. Epub 2018 Sep 23. No abstract available.

PMID:
30246240
10.

Use of immortal time within survival analysis.

Chan L, Byth K, Fernandez-Penas P.

J Am Acad Dermatol. 2019 Jan;80(1):e17. doi: 10.1016/j.jaad.2018.06.073. Epub 2018 Sep 15. No abstract available.

PMID:
30222986
11.

Lowering the P Value Threshold.

Gebski V, Byth K.

JAMA. 2018 Sep 4;320(9):935-936. doi: 10.1001/jama.2018.8729. No abstract available.

PMID:
30193270
12.

A low intensity dietary intervention for reducing excessive gestational weight gain in an overweight and obese pregnant cohort.

Dorise B, Byth K, McGee T, Wood A, Blumenthal C.

Eat Weight Disord. 2018 Aug 28. doi: 10.1007/s40519-018-0566-2. [Epub ahead of print]

PMID:
30155856
13.

School-Level Socioeconomic Status Influences Adolescents' Health-Related Lifestyle Behaviors and Intentions.

Shrewsbury VA, Foley BC, Flood VM, Bonnefin A, Hardy LL, Venchiarutti RL, Byth K, Shah S.

J Sch Health. 2018 Aug;88(8):583-589. doi: 10.1111/josh.12647.

PMID:
29992607
14.

A Retrospective Sequential Comparison of Topical Application of Medicated Honey and Povidone Iodine for Preventing Peritoneal Dialysis Catheter-Related Infections.

Wishart TFL, Aw L, Byth K, Rangan G, Sud K.

Perit Dial Int. 2018 Jul-Aug;38(4):302-305. doi: 10.3747/pdi.2017.00224.

PMID:
29987066
15.

Data maturity and follow-up in time-to-event analyses.

Gebski V, Garès V, Gibbs E, Byth K.

Int J Epidemiol. 2018 Feb 12. doi: 10.1093/ije/dyy013. [Epub ahead of print]

PMID:
29444326
16.

Concomitant Transcranial Direct Current Stimulation With Ultrabrief Electroconvulsive Therapy: A 2-Week Double-Blind Randomized Sham-Controlled Trial.

Mayur P, Howari R, Byth K, Vannitamby R.

J ECT. 2018 Dec;34(4):291-295. doi: 10.1097/YCT.0000000000000479.

PMID:
29369074
17.

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD).

Wong ATY, Mannix C, Grantham JJ, Allman-Farinelli M, Badve SV, Boudville N, Byth K, Chan J, Coulshed S, Edwards ME, Erickson BJ, Fernando M, Foster S, Haloob I, Harris DCH, Hawley CM, Hill J, Howard K, Howell M, Jiang SH, Johnson DW, Kline TL, Kumar K, Lee VW, Lonergan M, Mai J, McCloud P, Peduto A, Rangan A, Roger SD, Sud K, Torres V, Vliayuri E, Rangan GK.

BMJ Open. 2018 Jan 21;8(1):e018794. doi: 10.1136/bmjopen-2017-018794.

18.

Serum lactate cut-offs as a risk stratification tool for in-hospital adverse outcomes in emergency department patients screened for suspected sepsis.

Shetty AL, Thompson K, Byth K, Macaskill P, Green M, Fullick M, Lander H, Iredell J.

BMJ Open. 2018 Jan 5;8(1):e015492. doi: 10.1136/bmjopen-2016-015492.

19.

Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.

Greenawalt DM, Liang WS, Saif S, Johnson J, Todorov P, Dulak A, Enriquez D, Halperin R, Ahmed A, Saveliev V, Carpten J, Craig D, Barrett JC, Dougherty B, Zinda M, Fawell S, Dry JR, Byth K.

Oncotarget. 2017 Jun 15;8(59):99237-99244. doi: 10.18632/oncotarget.18502. eCollection 2017 Nov 21.

20.

Pre-clinical pharmacology of AZD3965, a selective inhibitor of MCT1: DLBCL, NHL and Burkitt's lymphoma anti-tumor activity.

Curtis NJ, Mooney L, Hopcroft L, Michopoulos F, Whalley N, Zhong H, Murray C, Logie A, Revill M, Byth KF, Benjamin AD, Firth MA, Green S, Smith PD, Critchlow SE.

Oncotarget. 2017 May 25;8(41):69219-69236. doi: 10.18632/oncotarget.18215. eCollection 2017 Sep 19.

21.

Comparing the effectiveness of general dietary advice versus a very low energy diet in an obese outpatient population in Australia.

Venchiarutti RL, Byth K, Marks JL, Chand A, Blumenthal CS.

Eat Weight Disord. 2017 Oct 11. doi: 10.1007/s40519-017-0443-4. [Epub ahead of print]

PMID:
29022288
22.

Evaluation of a peer education program on student leaders' energy balance-related behaviors.

Foley BC, Shrewsbury VA, Hardy LL, Flood VM, Byth K, Shah S.

BMC Public Health. 2017 Sep 7;17(1):695. doi: 10.1186/s12889-017-4707-8.

23.

Correction to Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.

McCoull W, Abrams RD, Anderson E, Blades K, Barton P, Box M, Burgess J, Byth K, Cao Q, Chuaqui C, Carbajo RJ, Cheung T, Code E, Ferguson AD, Fillery S, Fuller NO, Gangl E, Gao N, Grist M, Hargreaves D, Howard MR, Hu J, Kemmitt PD, Nelson JE, O'Connell N, Prince DB, Raubo P, Rawlins PB, Robb GR, Shi J, Waring MJ, Whittaker D, Wylot M, Zhu X.

J Med Chem. 2017 Jul 27;60(14):6459. doi: 10.1021/acs.jmedchem.7b00962. Epub 2017 Jul 17. No abstract available.

PMID:
28714680
24.

Risk Stratification for Covert Invasive Cancer Among Patients Referred for Colonic Endoscopic Mucosal Resection: A Large Multicenter Cohort.

Burgess NG, Hourigan LF, Zanati SA, Brown GJ, Singh R, Williams SJ, Raftopoulos SC, Ormonde D, Moss A, Byth K, Mahajan H, McLeod D, Bourke MJ.

Gastroenterology. 2017 Sep;153(3):732-742.e1. doi: 10.1053/j.gastro.2017.05.047. Epub 2017 Jun 2.

PMID:
28583826
25.

Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro.

Chen SC, Patel S, Meyer W, Chapman B, Yu H, Byth K, Middleton PG, Nevalainen H, Sorrell TC.

Mycopathologia. 2018 Feb;183(1):251-261. doi: 10.1007/s11046-017-0140-x. Epub 2017 May 16.

PMID:
28512704
26.

Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (BCL6) Binders and Optimization to High Affinity Macrocyclic Inhibitors.

McCoull W, Abrams RD, Anderson E, Blades K, Barton P, Box M, Burgess J, Byth K, Cao Q, Chuaqui C, Carbajo RJ, Cheung T, Code E, Ferguson AD, Fillery S, Fuller NO, Gangl E, Gao N, Grist M, Hargreaves D, Howard MR, Hu J, Kemmitt PD, Nelson JE, O'Connell N, Prince DB, Raubo P, Rawlins PB, Robb GR, Shi J, Waring MJ, Whittaker D, Wylot M, Zhu X.

J Med Chem. 2017 May 25;60(10):4386-4402. doi: 10.1021/acs.jmedchem.7b00359. Epub 2017 May 9. Erratum in: J Med Chem. 2017 Jul 27;60(14):6459.

PMID:
28485934
27.

Endoscopic resection of large duodenal and papillary lateral spreading lesions is clinically and economically advantageous compared with surgery.

Klein A, Ahlenstiel G, Tate DJ, Burgess N, Richardson A, Pang T, Byth K, Bourke MJ.

Endoscopy. 2017 Jul;49(7):659-667. doi: 10.1055/s-0043-105484. Epub 2017 Apr 4.

PMID:
28376545
28.

Adenoma recurrence after piecemeal colonic EMR is predictable: the Sydney EMR recurrence tool.

Tate DJ, Desomer L, Klein A, Brown G, Hourigan LF, Lee EY, Moss A, Ormonde D, Raftopoulos S, Singh R, Williams SJ, Zanati S, Byth K, Bourke MJ.

Gastrointest Endosc. 2017 Mar;85(3):647-656.e6. doi: 10.1016/j.gie.2016.11.027. Epub 2016 Nov 28.

PMID:
27908600
29.

Broad activation of latent HIV-1 in vivo.

Barton K, Hiener B, Winckelmann A, Rasmussen TA, Shao W, Byth K, Lanfear R, Solomon A, McMahon J, Harrington S, Buzon M, Lichterfeld M, Denton PW, Olesen R, Østergaard L, Tolstrup M, Lewin SR, Søgaard OS, Palmer S.

Nat Commun. 2016 Sep 8;7:12731. doi: 10.1038/ncomms12731.

30.

Deep mural injury and perforation after colonic endoscopic mucosal resection: a new classification and analysis of risk factors.

Burgess NG, Bassan MS, McLeod D, Williams SJ, Byth K, Bourke MJ.

Gut. 2017 Oct;66(10):1779-1789. doi: 10.1136/gutjnl-2015-309848. Epub 2016 Jul 27.

PMID:
27464708
31.

Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia.

Bradstock KF, Morley A, Byth K, Szer J, Prosser I, Cannell P, Irving I, Seymour JF.

Contemp Clin Trials Commun. 2016 Jun 22;4:9-13. doi: 10.1016/j.conctc.2016.06.004. eCollection 2016 Dec 15.

32.

Prediction of Clinically Significant Bleeding Following Wide-Field Endoscopic Resection of Large Sessile and Laterally Spreading Colorectal Lesions: A Clinical Risk Score.

Bahin FF, Rasouli KN, Byth K, Hourigan LF, Singh R, Brown GJ, Zanati SA, Moss A, Raftopoulos S, Williams SJ, Bourke MJ.

Am J Gastroenterol. 2016 Aug;111(8):1115-22. doi: 10.1038/ajg.2016.235. Epub 2016 Jun 14.

PMID:
27296942
33.

Riluzole exerts transient modulating effects on cortical and axonal hyperexcitability in ALS.

Geevasinga N, Menon P, Ng K, Van Den Bos M, Byth K, Kiernan MC, Vucic S.

Amyotroph Lateral Scler Frontotemporal Degener. 2016 Oct - Nov;17(7-8):580-588. Epub 2016 Jun 1.

PMID:
27249331
34.

Prevalence of thyroid dysfunction and thyroid antibodies in a private obstetrical practice in Sydney.

Blumenthal NJ, Byth K, Eastman CJ.

Aust N Z J Obstet Gynaecol. 2016 Jun;56(3):307-11. doi: 10.1111/ajo.12462. Epub 2016 Mar 23.

PMID:
27004843
35.

Perceived incivility during emergency department phone consultations.

Shetty AL, Vaghasiya M, Boddy R, Byth K, Unwin D.

Emerg Med Australas. 2016 Jun;28(3):256-61. doi: 10.1111/1742-6723.12564. Epub 2016 Mar 16.

PMID:
26992054
36.

Endoscopic mucosal resection of large and giant lateral spreading lesions of the duodenum: success, adverse events, and long-term outcomes.

Klein A, Nayyar D, Bahin FF, Qi Z, Lee E, Williams SJ, Byth K, Bourke MJ.

Gastrointest Endosc. 2016 Oct;84(4):688-96. doi: 10.1016/j.gie.2016.02.049. Epub 2016 Mar 11.

PMID:
26975231
37.

Differential regulation of mTOR signaling determines sensitivity to AKT inhibition in diffuse large B cell lymphoma.

Ezell SA, Wang S, Bihani T, Lai Z, Grosskurth SE, Tepsuporn S, Davies BR, Huszar D, Byth KF.

Oncotarget. 2016 Feb 23;7(8):9163-74. doi: 10.18632/oncotarget.7036.

38.

Cutaneous adverse events (AEs) of anti-programmed cell death (PD)-1 therapy in patients with metastatic melanoma: A single-institution cohort.

Hwang SJ, Carlos G, Wakade D, Byth K, Kong BY, Chou S, Carlino MS, Kefford R, Fernandez-Penas P.

J Am Acad Dermatol. 2016 Mar;74(3):455-61.e1. doi: 10.1016/j.jaad.2015.10.029. Epub 2016 Jan 12.

PMID:
26793994
39.

Endoscopic mucosal resection for large serrated lesions in comparison with adenomas: a prospective multicentre study of 2000 lesions.

Pellise M, Burgess NG, Tutticci N, Hourigan LF, Zanati SA, Brown GJ, Singh R, Williams SJ, Raftopoulos SC, Ormonde D, Moss A, Byth K, P'Ng H, Mahajan H, McLeod D, Bourke MJ.

Gut. 2017 Apr;66(4):644-653. doi: 10.1136/gutjnl-2015-310249. Epub 2016 Jan 19.

PMID:
26786685
40.

Time-Dependent Measurement of Adverse Events.

Hwang SJ, Byth K, Fernandez-Penas P.

JAMA Dermatol. 2015 Dec 1;151(12):1392. doi: 10.1001/jamadermatol.2015.3579. No abstract available.

PMID:
26650663
41.

Reduced complications from intracranial grid insertion by using a small grid size and a precise protocol during monitoring.

Rahman Z, Bleasel AF, Bartley M, Dexter M, Galea T, Gill D, Soe S, Byth K, Wong CH.

Acta Neurochir (Wien). 2016 Feb;158(2):395-403; discussion 402-3. doi: 10.1007/s00701-015-2647-6. Epub 2015 Dec 9.

PMID:
26645281
42.

Outcomes in Stapedotomy Surgery: The Learning Curve Redefined.

Watson GJ, Byth K, da Cruz M.

Otol Neurotol. 2015 Dec;36(10):1601-3. doi: 10.1097/MAO.0000000000000887. Review.

PMID:
26496671
43.

Identification and Optimization of Benzimidazole Sulfonamides as Orally Bioavailable Sphingosine 1-Phosphate Receptor 1 Antagonists with in Vivo Activity.

Hennessy EJ, Oza V, Adam A, Byth K, Castriotta L, Grewal G, Hamilton GA, Kamhi VM, Lewis P, Li D, Lyne P, Öster L, Rooney MT, Saeh JC, Sha L, Su Q, Wen S, Xue Y, Yang B.

J Med Chem. 2015 Sep 10;58(17):7057-75. doi: 10.1021/acs.jmedchem.5b01078. Epub 2015 Aug 26.

PMID:
26291341
44.

Rate of disease progression: a prognostic biomarker in ALS.

Labra J, Menon P, Byth K, Morrison S, Vucic S.

J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):628-32. doi: 10.1136/jnnp-2015-310998. Epub 2015 Jul 7.

PMID:
26152368
45.

Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.

Rahman Z, Wong CH, Dexter M, Olsson G, Wong M, Gebsky V, Nahar N, Wood A, Byth K, King M, Bleasel AB.

Epilepsy Behav. 2015 Jul;48:88-95. doi: 10.1016/j.yebeh.2015.03.016. Epub 2015 Jun 29.

PMID:
26136184
46.

Influence of Stem Cell Source on Outcomes of Allogeneic Reduced-Intensity Conditioning Therapy Transplants Using Haploidentical Related Donors.

Bradstock K, Bilmon I, Kwan J, Blyth E, Micklethwaite K, Huang G, Deren S, Byth K, Gottlieb D.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1641-5. doi: 10.1016/j.bbmt.2015.06.006. Epub 2015 Jun 14.

47.

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial.

Mote PA, Gompel A, Howe C, Hilton HN, Sestak I, Cuzick J, Dowsett M, Hugol D, Forgez P, Byth K, Graham JD, Clarke CL.

Breast Cancer Res Treat. 2015 Jun;151(2):309-18. doi: 10.1007/s10549-015-3397-0. Epub 2015 Apr 28.

PMID:
25917868
48.

Discovery of heterocyclic sulfonamides as sphingosine 1-phosphate receptor 1 (S1P1) antagonists.

Hennessy EJ, Grewal G, Byth K, Kamhi VM, Li D, Lyne P, Oza V, Ronco L, Rooney MT, Saeh JC, Su Q.

Bioorg Med Chem Lett. 2015;25(10):2041-5. doi: 10.1016/j.bmcl.2015.03.095. Epub 2015 Apr 8.

PMID:
25890801
49.

Computed tomography-guided in vivo cardiac orientation and correlation with ECG in individuals without structural heart disease and in age-matched obese and older individuals.

Sathananthan G, Aggarwal G, Zahid S, Byth K, Chik W, Friedman D, Thiagalingam A.

Clin Anat. 2015 May;28(4):487-93. doi: 10.1002/ca.22532. Epub 2015 Apr 2.

PMID:
25832755
50.

Factors influencing the development of cutaneous squamous cell carcinoma in patients on BRAF inhibitor therapy.

Anforth R, Menzies A, Byth K, Carlos G, Chou S, Sharma R, Scolyer RA, Kefford R, Long GV, Fernandez-Peñas P.

J Am Acad Dermatol. 2015 May;72(5):809-15.e1. doi: 10.1016/j.jaad.2015.01.018. Epub 2015 Mar 3.

PMID:
25748298

Supplemental Content

Support Center